Cytokine Levels in Conversion Disorder | NCT00971360

Studies
Cytokine Levels in Conversion Disorder

NCT00971360

Sponsor

Trakya University

Status

Completed

Last Update Posted

Oct 20, 2010Estimated

Enrollment

30Estimated

Phase

Not provided

Conditions

Conversion Disorder

Interventions

conversion disorder

Countries

Turkey (Türkiye)

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Sep 2009

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Sep 2009

Primary Completion Date

Sep 2010Actual

Completion Date

Sep 2010Actual

First Submitted Date

Sep 2, 2009

First Submission Date that Met QC Criteria

Sep 2, 2009

First Posted Date

Sep 3, 2009Estimated

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Oct 19, 2010

Last Update Posted Date

Oct 20, 2010Estimated

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The aim of this study is whether the proinflammatory cytokine levels in patients with conversion disorder is increased or not changed in the acute phase and subacute - chronic periode, compared with controls.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

30Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Conversion disorder			Other: conversion disorder
Healthy control			Other: conversion disorder

Interventions

Name	Type	Description	Arm Group Labels	Other Names
conversion disorder	Other	Proinflammatory cytokine levels in conversion disorder	Conversion disorder Healthy control

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Clinical diagnosis of Alzheimer's Disease

Exclusion Criteria:

Autoimmune disease
Neurological disease
Any organic disorder that could possibly affect proinflammatory cytokines
Pregnancy
Any drug usage within 2 weeks
Any active or passive immunization within 6 months
Any other DSM-IV axis I psychiatric disorder
Mental retardation
Developmental disorder of childhood

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

65 Years

Standard Ages

AdultOlder Adult

Study Population

primary care clinic

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Trakya University Faculty of Medicine; Department of Psychiatry		Edirne		22030	Turkey (Türkiye)

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
11814536	Background	Rief W, Pilger F, Ihle D, Bosmans E, Egyed B, Maes M. Immunological differences between patients with major depression and somatization syndrome. Psychiatry Res. 2001 Dec 31;105(3):165-74. doi: 10.1016/s0165-1781(01)00338-9.
17503136	Background	Ziemssen T, Kern S. Psychoneuroimmunology--cross-talk between the immune and nervous systems. J Neurol. 2007 May;254 Suppl 2:II8-11. doi: 10.1007/s00415-007-2003-8.

ID	Term
D003291	Conversion Disorder
D007249	Inflammation

ID	Term
D013001	Somatoform Disorders
D001523	Mental Disorders
D010335	Pathologic Processes
D013568	Pathological Conditions, Signs and Symptoms